Mark K. Ferguson to Female
This is a "connection" page, showing publications Mark K. Ferguson has written about Female.
Connection Strength
1.073
-
Gender Bias in Judging Frailty and Fitness for Lung Surgery. Ann Thorac Surg. 2023 02; 115(2):356-361.
Score: 0.041
-
A Morphomic Index Is an Independent Predictor of Survival After Lung Cancer Resection. Ann Thorac Surg. 2020 03; 109(3):873-878.
Score: 0.035
-
Gender Bias Affects Assessment of Frailty and Recommendations for Surgery. Ann Thorac Surg. 2020 03; 109(3):938-944.
Score: 0.034
-
Physician Gender Differences in Processing Surgical Risk Features in Videos of Standardized Patients. Ann Thorac Surg. 2019 04; 107(4):1248-1252.
Score: 0.033
-
Do Estimates of Treatment Risk Based on Clinical Vignettes Differ by Physician Gender? Ann Thorac Surg. 2018 12; 106(6):1868-1872.
Score: 0.032
-
Does Race Influence Risk Assessment and Recommendations for Lung Resection? A Randomized Trial. Ann Thorac Surg. 2018 10; 106(4):1013-1017.
Score: 0.032
-
The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection. Ann Thorac Surg. 2017 Jul; 104(1):284-289.
Score: 0.029
-
Screening for Frailty in Thoracic Surgical Patients. Ann Thorac Surg. 2017 Mar; 103(3):956-961.
Score: 0.028
-
Lung function predicts pulmonary complications regardless of the surgical approach. Ann Thorac Surg. 2015 May; 99(5):1761-7.
Score: 0.025
-
Reply: To PMID 24565405. Ann Thorac Surg. 2014 Oct; 98(4):1525-6.
Score: 0.025
-
Thoracic surgeons' perception of frail behavior in videos of standardized patients. PLoS One. 2014; 9(6):e98654.
Score: 0.024
-
The impact of perceived frailty on surgeons' estimates of surgical risk. Ann Thorac Surg. 2014 Jul; 98(1):210-6.
Score: 0.024
-
Prediction of major cardiovascular events after lung resection using a modified scoring system. Ann Thorac Surg. 2014 Apr; 97(4):1135-40.
Score: 0.024
-
Association of body mass index and outcomes after major lung resection. Eur J Cardiothorac Surg. 2014 Apr; 45(4):e94-9; discussion e99.
Score: 0.024
-
Competence versus mastery: the time course for developing proficiency in video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2014 Apr; 147(4):1150-4.
Score: 0.023
-
Predicted postoperative lung function is associated with all-cause long-term mortality after major lung resection for cancer. Eur J Cardiothorac Surg. 2014 Apr; 45(4):660-4.
Score: 0.023
-
Editorial comment: inflationary pressures. Eur J Cardiothorac Surg. 2012 Sep; 42(3):403-4.
Score: 0.021
-
Validation of a modified scoring system for cardiovascular risk associated with major lung resection. Eur J Cardiothorac Surg. 2012 Mar; 41(3):598-602.
Score: 0.020
-
Assessment of a scoring system for predicting complications after esophagectomy. Dis Esophagus. 2011 Sep; 24(7):510-5.
Score: 0.019
-
Editorial comment: Back to the future: chest physiotherapy comes full circle. Eur J Cardiothorac Surg. 2011 Jul; 40(1):134-5.
Score: 0.019
-
Estimating lung resection risk: a pilot study of trainee and practicing surgeons. Ann Thorac Surg. 2010 Apr; 89(4):1037-42; discussion 1042-3.
Score: 0.018
-
Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity. J Thorac Cardiovasc Surg. 2009 Dec; 138(6):1297-302.
Score: 0.017
-
Quality of life and mood in older patients after major lung resection. Ann Thorac Surg. 2009 Apr; 87(4):1007-12; discussion 1012-3.
Score: 0.017
-
Modeling major lung resection outcomes using classification trees and multiple imputation techniques. Eur J Cardiothorac Surg. 2008 Nov; 34(5):1085-9.
Score: 0.016
-
Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg. 2008 Apr; 85(4):1158-64; discussion 1164-5.
Score: 0.016
-
Bowel necrosis associated with early jejunal tube feeding: A complication of postoperative enteral nutrition. Arch Surg. 2006 Jul; 141(7):701-4.
Score: 0.014
-
Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg. 2004 Nov; 78(5):1783-9.
Score: 0.012
-
Barriers and facilitators to smartwatch-based prehabilitation participation among frail surgery patients: a qualitative study. BMC Geriatr. 2024 Feb 02; 24(1):129.
Score: 0.012
-
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Netw Open. 2023 08 01; 6(8):e2327351.
Score: 0.011
-
Postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 2003 Jun; 17(3):388-95.
Score: 0.011
-
A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg. 2003 Jan; 23(1):35-42.
Score: 0.011
-
Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2002 Apr; 123(4):661-9.
Score: 0.010
-
Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg. 2002 Jan-Feb; 6(1):29-35; discussion 36.
Score: 0.010
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.010
-
Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 09 01; 156(9):836-845.
Score: 0.010
-
U.S. trends in elective and emergent major abdominal surgical procedures from 2002 to 2014 in older adults. J Am Geriatr Soc. 2021 08; 69(8):2220-2230.
Score: 0.010
-
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
Score: 0.009
-
Long-term outcome after resection for bronchial carcinoid tumors. Eur J Cardiothorac Surg. 2000 Aug; 18(2):156-61.
Score: 0.009
-
Does pneumonectomy for lung cancer adversely influence long-term survival? J Thorac Cardiovasc Surg. 2000 Mar; 119(3):440-8.
Score: 0.009
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.009
-
Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg. 2000 Jan; 69(1):245-9; discussion 249-50.
Score: 0.009
-
Diffusing capacity predicts operative mortality but not long-term survival after resection for lung cancer. J Thorac Cardiovasc Surg. 1999 Mar; 117(3):581-6; discussion 586-7.
Score: 0.008
-
Translating Frailty Research Into Clinical Practice: Insights From the Successful Aging and Frailty Evaluation Clinic. J Am Med Dir Assoc. 2019 06; 20(6):672-678.
Score: 0.008
-
Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997 Nov; 114(5):824-9.
Score: 0.008
-
Effect of Endoscopic Bronchial Ultrasound on Outcomes for Stage I Non-Small-Cell Lung Cancer Patients Receiving Hypofractionated Radiotherapy. Clin Lung Cancer. 2018 03; 19(2):e227-e233.
Score: 0.008
-
Coronary artery disease is associated with an increased mortality rate following video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2017 07; 154(1):352-357.
Score: 0.007
-
Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2017 Aug; 44(8):1275-1284.
Score: 0.007
-
Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer. Nucl Med Commun. 2017 Feb; 38(2):185-192.
Score: 0.007
-
Outcome after failed initial therapy for rupture of the esophagus or intrathoracic stomach. J Gastrointest Surg. 1997 Jan-Feb; 1(1):34-9.
Score: 0.007
-
Use of pleural catheter for the management of simple pneumothorax. Chest. 1996 Nov; 110(5):1169-72.
Score: 0.007
-
Results of myotomy and partial fundoplication after pneumatic dilation for achalasia. Ann Thorac Surg. 1996 Aug; 62(2):327-30.
Score: 0.007
-
Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy. Technol Cancer Res Treat. 2017 02; 16(1):15-21.
Score: 0.007
-
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation. Oncotarget. 2016 Apr 05; 7(14):18876-86.
Score: 0.007
-
Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
Score: 0.007
-
Retroperitoneal placement of an ICD generator: a solution for a difficult problem. Pacing Clin Electrophysiol. 1996 Jan; 19(1):130-1.
Score: 0.007
-
Right Ventricular Apical Flattening as an Echocardiographic Screening Tool for Right Ventricular Enlargement. Pediatr Cardiol. 2016 Mar; 37(3):568-74.
Score: 0.007
-
Current results of therapy for esophageal perforation. Am J Surg. 1995 Jun; 169(6):615-7.
Score: 0.006
-
Thoracic Revised Cardiac Risk Index Is Associated With Prognosis After Resection for Stage I Lung Cancer. Ann Thorac Surg. 2015 Jul; 100(1):195-200.
Score: 0.006
-
Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 1995 Mar; 2(2):101-6.
Score: 0.006
-
External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†. Eur J Cardiothorac Surg. 2016 Jan; 49(1):333-8.
Score: 0.006
-
Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):275-81; discussion 281-3.
Score: 0.006
-
How accurate are anatomic landmarks for femoral tunnel positioning in anterior cruciate ligament reconstruction? An in vivo imaging analysis comparing both anteromedial portal and outside-in techniques. Arthroscopy. 2015 May; 31(5):882-9.
Score: 0.006
-
Modulation of lymphatic spontaneous contractions by EDRF. J Surg Res. 1994 Jun; 56(6):620-5.
Score: 0.006
-
Characterization of contractile properties of porcine mesenteric and tracheobronchial lymphatic smooth muscle. Lymphology. 1994 Jun; 27(2):71-81.
Score: 0.006
-
Nitric oxide and endothelium-dependent relaxation in tracheobronchial lymph vessels. Microvasc Res. 1994 May; 47(3):308-17.
Score: 0.006
-
Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
Score: 0.006
-
Transcervical thymectomy for myasthenia gravis. Ann Thorac Surg. 1994 Jan; 57(1):194-7.
Score: 0.006
-
Heterogeneity of tracheobronchial lymphatic smooth muscle responses to histamine and 5-hydroxytryptamine. Lymphology. 1993 Sep; 26(3):113-9.
Score: 0.006
-
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013 Jul; 8(7):915-22.
Score: 0.006
-
Length-tension characteristics of bovine tracheobronchial lymphatic smooth muscle. Lymphology. 1993 Mar; 26(1):19-24.
Score: 0.006
-
Adenocarcinoma in Barrett's esophagus. Semin Thorac Cardiovasc Surg. 1992 Oct; 4(4):276-9.
Score: 0.005
-
Modulation of lymphatic smooth muscle contractile responses by the endothelium. J Surg Res. 1992 Apr; 52(4):359-63.
Score: 0.005
-
Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):446-50.
Score: 0.005
-
MET and phosphorylated MET as potential biomarkers in lung cancer. J Environ Pathol Toxicol Oncol. 2011; 30(4):341-54.
Score: 0.005
-
Predicting failure following shunting of pleural effusions. Chest. 1990 Oct; 98(4):890-3.
Score: 0.005
-
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
Score: 0.005
-
Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
Score: 0.005
-
Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis. Eur J Cardiothorac Surg. 2010 Mar; 37(3):535-9.
Score: 0.004
-
Ethnic differences and functional analysis of MET mutations in lung cancer. Clin Cancer Res. 2009 Sep 15; 15(18):5714-23.
Score: 0.004
-
Early evaluation and therapy for caustic esophageal injury. Am J Surg. 1989 Jan; 157(1):116-20.
Score: 0.004
-
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma. Arch Pathol Lab Med. 2008 Dec; 132(12):1882-8.
Score: 0.004
-
Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg. 1988 Dec; 96(6):894-900.
Score: 0.004
-
A scoring system predicting the risk for intensive care unit admission for complications after major lung resection: a multicenter analysis. Ann Thorac Surg. 2008 Jul; 86(1):213-8.
Score: 0.004
-
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. J Thorac Oncol. 2008 Jan; 3(1):59-67.
Score: 0.004
-
Selective operative approach for diagnosis and treatment of anterior mediastinal masses. Ann Thorac Surg. 1987 Dec; 44(6):583-6.
Score: 0.004
-
Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol. 2007 Jun; 30(3):258-63.
Score: 0.004
-
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
Score: 0.002
-
Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: a long-term analysis. Ann Oncol. 1998 Jun; 9(6):647-51.
Score: 0.002
-
Management of giant paraesophageal hernia. Dis Esophagus. 1997 Jan; 10(1):47-50.
Score: 0.002
-
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
Score: 0.002
-
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
Score: 0.002
-
Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer. 1993 Aug 01; 72(3):714-8.
Score: 0.001
-
Forequarter amputation wound coverage with an ipsilateral, lymphedematous, circumferential forearm fasciocutaneous free flap in patients undergoing palliative shoulder-girdle tumor resection. J Reconstr Microsurg. 1993 Mar; 9(2):103-7.
Score: 0.001
-
The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
Score: 0.001
-
Pericardial window: mechanisms of efficacy. Ann Thorac Surg. 1990 Sep; 50(3):442-5.
Score: 0.001
-
5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer. 1990 Aug 01; 66(3):437-42.
Score: 0.001
-
Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
Score: 0.001
-
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 1989 Jul; 96(1):110-3.
Score: 0.001
-
Treatment of carcinoma of the proximal esophagus. Surg Gynecol Obstet. 1989 Apr; 168(4):307-10.
Score: 0.001
-
Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg. 1988 Oct; 208(4):443-50.
Score: 0.001
-
Surgical management of esophageal strictures. Ann Thorac Surg. 1988 Feb; 45(2):144-7.
Score: 0.001
-
Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
Score: 0.001
-
Colon interposition for benign esophageal disease. Surgery. 1987 Oct; 102(4):568-74.
Score: 0.001